The future of iPSCs in cell biology is incredibly promising. Ongoing research aims to improve the efficiency and safety of the reprogramming process, develop non-integrative methods for factor delivery, and understand the mechanisms underlying pluripotency and differentiation. Advances in genome editing technologies, such as CRISPR/Cas9, are enhancing the ability to correct genetic defects in iPSCs, paving the way for personalized therapies. As our understanding of iPSCs continues to grow, their potential applications in regenerative medicine, disease modeling, and drug discovery are expected to expand, offering new hope for treating a wide range of conditions.
